Overcast 64°
Tag:

COVID-19 vaccines

News
COVID-19: CDC Issues Risk Assessment On New Pirola Variant As Hospitalizations Increase 21.6% COVID-19: CDC Issues Risk Assessment On New Pirola Variant As Hospitalizations Increase 21.6%
Covid-19: CDC Issues Risk Assessment On New Pirola Variant As Hospitalizations Increase 21.6% COVID-19 hospitalizations saw a 21.6 percent jump in one week according to the latest data reported by the Centers for Disease Control and Prevention (CDC), which has just released new information on a brand-new highly mutated variant. New increases are expected for the next month, the agency is now projecting. The news comes as the CDC and World Health Organization (WHO) are monitoring the newly identified BA.2.86 strain, now known as Pirola, which has around 30 mutations. The second figure above shows the number of daily COVID hospitalizations in the US each day from Thursday, June 13 th…

SHARE

by Joe Lombardi
News
COVID-19: Subvariant XBB Accounts For 70% Of New England Cases, Sparking Concerns Of New Wave COVID-19: Subvariant XBB Accounts For 70% Of New England Cases, Sparking Concerns Of New Wave
Covid-19: Subvariant XBB Accounts For 70% Of New England Cases, Sparking Concerns Of New Wave An Omicron strain called XBB.1.5 which now accounts for the majority of COVID-19 cases from the New York tristate area through New England has the potential to trigger a new wave of infections, a top expert is now saying. The XBB.1.5 variant makes up 40.5 percent of cases in the United States, and 70 percent of cases in the New York tristate area through New England, according to the Centers for Disease Control and Prevention (CDC). "I would expect a wave of infection with this new variant," Dr. Scott Gottlieb, former commissioner of the Food and Drug Administration (FDA), told MS…

SHARE

by Joe Lombardi
News
COVID-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel COVID-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel
Covid-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel Federal health officials are moving closer to authorizing COVID-19 vaccines for the youngest Americans. The US Food and Drug Administration (FDA) voted on Wednesday, June 15 to recommend authorizing both the Moderna and Pfizer COVID-19 vaccines for children between the ages of 6 months and 5 years old. On Wednesday, the agency’s independent panel of experts voted to recommend the vaccines - which are currently only available for Americans 5 years and older - for younger children. All 21 members of the FDA's Vaccines and Related Biological Products Advisory Committee unanimously voted to a…

SHARE

by Zak Failla